Home » Topics » Regulatory » Patents

Patents
RSS

Novel glucosylceramidase activators presented by Lysosomal Therapeutics

Nov. 21, 2017

Melinta Therapeutics presents compounds for treating bacterial infections

Nov. 21, 2017

University of Texas System identifies novel sigma1/2 receptor modulators

Nov. 20, 2017

Sumitomo Dainippon Pharma discloses TLR7 antagonists

Nov. 20, 2017

University of California, Oakland divulges erbB inhibitors

Nov. 20, 2017

Rudong SIMR Biotech identifies novel GABRA5 inverse agonists

Nov. 20, 2017

Genoscience Pharma presents compounds for treating cancer

Nov. 20, 2017

Amgen presents novel apelin receptor agonists

Nov. 17, 2017

Shanghai De Novo Pharmatech has presented TLR8 agonists

Nov. 17, 2017

GlaxoSmithKline discloses novel EZH2 inhibitors

Nov. 17, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...